K90-K95Other diseases of the digestive system K91-Intraoperative and postprocedural complications and disorders of digestive system, not elsewhere classified 2022 ICD-10-CM Diagnosis Code K91.83 2022 ICD-10-CM Diagnosis Code K91.83 Postprocedural hepatorenal syndrome 2016201720182019202020212022Billable/Specific Code
2018/2019 ICD-10-CM Diagnosis Code K72.9. Hepatic failure, unspecified. K72.9 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
K76.7 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM K76.7 became effective on October 1, 2021. This is the American ICD-10-CM version of K76.7 - other international versions of ICD-10 K76.7 may differ. A type 1 excludes note is a pure excludes.
alcoholic liver disease ( K70.-) amyloid degeneration of liver ( E85.-) toxic liver disease ( K71.-) Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
ICD-10-CM Code for Hepatorenal syndrome K76. 7.
Hepatorenal syndrome (HRS) is a form of impaired kidney function that occurs in individuals with advanced liver disease. Individuals with hepatorenal syndrome do not have any identifiable cause of kidney dysfunction and the kidneys themselves are not structural damaged.
Two forms of hepatorenal syndrome have been defined: Type 1 HRS entails a rapidly progressive decline in kidney function, while type 2 HRS is associated with ascites (fluid accumulation in the abdomen) that does not improve with standard diuretic medications.
RELATED TOPICS. The hepatorenal syndrome is one of many potential causes of acute kidney injury in patients with acute or chronic liver disease.
Acute kidney injury (AKI) in the setting of cirrhosis (hepatorenal syndrome [HRS]–AKI) is a severe and often fatal complication of end-stage liver disease. The goals of treatment are to reverse renal failure and prolong survival in patients who are critically ill.
Type I HRS (HRS-1) is characterized by an abrupt deterioration in renal function (in less than 2 weeks), defined by a doubling of baseline sCr to >2.5 mg/dL or a 50% reduction in the initial 24 hrs creatinine clearance to <20 mL/min.
HRS is the most advanced stage of the various pathophysiologic derangements that take place in patients with cirrhosis. The hallmark of HRS is intense renal vasoconstriction that starts at an early time point and progresses with worsening of the liver disease (7).
Albumin infusions have been used in the management of patients with cirrhosis and ascites with two main objectives: (1) to reduce the formation of ascites and oedema by increasing microvascular oncotic pressure; and (2) to improve circulatory and renal function by expanding total blood volume.
Death often results from a combination of hepatic and renal failure or variceal bleeding. Type 2 hepatorenal syndrome usually occurs in patients with diuretic resistant ascites. Renal failure has a slow course, in which it may deteriorate over months.
Prerenal AKI, the hepatorenal syndrome (HRS), also known as HRS type 1, a particular form of prerenal AKI in liver cirrhosis, and acute tubular necrosis (ATN) represent the most common causes of renal dysfunction in cirrhotic patients.
These medications have shown promise for the treatment of HRS; they include vasopressin analogues (ornipressin, terlipressin), somatostatin analogues (octreotide), and alpha-adrenergic agonists (midodrine).
K76.7 is a valid billable ICD-10 diagnosis code for Hepatorenal syndrome . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. Heyd's K76.7.